Philippe Moingeon

Philippe Moingeon received his PhD in Immunology from Paris XI University (France) and an MBA from Open University Business School (Newcastle, UK). As a former Assistant Professor at Harvard Medical School (Boston, USA), he specialized in the development of biologicals and immunotherapies, holding several leadership positions in the vaccine and pharmaceutical industries. He joined Servier in 2017, to head the therapeutic area developing new treatments for immuno-inflammatory diseases. Philippe has also developed two vaccines registered in Europe, USA and Japan, is the author of 230 scientific publications in peer-reviewed journals and has 23 patents/patent applications. His research interests encompass artificial intelligence applications to drug development, medicine of the future and technological evolution of mankind.